We aimed to investigate if respiration gated quantitative FDG-PET/CT measures, as surrogate for pulmonary inflammation, as well as markers of systemic inflammation are reduced in patients with COPD treated with GLP-1 RA for 40 weeks. This evidence concerns the gene GLP1R and chronic obstructive pulmonary disease.